Heterogeneity in the treatment effect of sodium-glucose cotransporter-2 inhibitor on chronic kidney disease risk reduction: a prevalent new user cohort study applying double/debiased machine learning.
Overview & Synopsis
Open access biomedical research article published in Diabetol Metab Syndr.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Heterogeneity in the treatment effect of sodium-glucose cotransporter-2 inhibitor on chronic kidney disease risk reduction: a prevalent new user cohort study applying double/debiased machine learning. |
|---|---|
| Author / Organization | Kongmalai T, Looareesuwan P, Tansawet A, Siriyotha S, Kunakorntham P, Boonwatcharapai B, Attia J, McKay GJ, Thakkinstian A |
| Subject & Discipline | Diabetol Metab Syndr |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-61189 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |